Clinical Trial Update: Ivonescimab Before Surgery for the Treatment of Resectable Stage II-IV Head and Neck Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating Ivonescimab given before surgery in patients with resectable stage II-IV head and neck squamous cell carcinoma, and the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Ivonescimab (AK112/SMT112)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Advanced Head and Neck Squamous Cell Carcinoma, Resectable Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: RECRUITING